Clinical Trials Browser

Carcinoma, Intraductal, Noninfiltrating × Colony-Stimulating Factors × 90 days × Clear all

NCT04144023 2026-03-05

A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ

Phase 1 Recruiting

Carcinoma, Intraductal, Noninfiltrating